文献速递脑血管病

卒中亚型与血管内治疗后出血转化相关:取栓次数起中介作用——来自ANGEL-ACT登记研究的数据

Association of Stroke Subtype With Hemorrhagic Transformation Mediated by Thrombectomy Pass: Data From the ANGEL-ACT Registry.
PubMed 文献 · Stroke · 2022-03-31

基于ANGEL-ACT前瞻性连续队列中1015例急性大血管闭塞行血管内治疗患者,按TOAST标准分为大动脉粥样硬化组538例与心源性栓塞组477例。心源性栓塞组术后24小时内任何颅内出血、脑实质血肿及症状性颅内出血风险均高于大动脉粥样硬化组,取栓次数部分中介该关联。

要点

  • 心源性栓塞较大动脉粥样硬化任何颅内出血风险升高:29.8% vs 16.5%,OR 2.03(95%CI 1.22-3.36)。
  • 心源性栓塞组脑实质血肿风险升高:14.3% vs 5.4%,OR 2.90(95%CI 1.38-6.13)。
  • 取栓次数对卒中亚型与出血转化的关联有显著中介效应,任何颅内出血中介比例15.9%。

核心结论

  • 卒中亚型是急性大血管闭塞患者血管内治疗后24小时内出血转化的独立危险因素。
  • 中介分析提示卒中亚型部分通过取栓次数影响出血转化,可能存在病理机制联系。

研究设计与样本

  • 研究为前瞻性连续队列,数据来自ANGEL-ACT登记研究,纳入中国111家医院2017年11月至2019年3月间接受血管内治疗的急性大血管闭塞患者。
  • 共选取1015例受试者,按TOAST标准分为大动脉粥样硬化组(n=538)与心源性栓塞组(n=477)。

主要发现

  • 心源性栓塞组与大动脉粥样硬化组相比,任何颅内出血发生率为29.8% vs 16.5%,OR 2.03(95%CI 1.22-3.36)。
  • 心源性栓塞组与大动脉粥样硬化组相比,脑实质血肿发生率为14.3% vs 5.4%,OR 2.90(95%CI 1.38-6.13)。
  • 心源性栓塞组与大动脉粥样硬化组相比,症状性颅内出血发生率为9.9% vs 4.7%,OR 2.59(95%CI 1.09-6.16)。
  • 取栓次数对卒中亚型与出血转化关联的中介效应分别为:任何颅内出血15.9%、脑实质血肿13.4%、症状性颅内出血14.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of stroke etiology subtype in patients with acute large vessel occlusion on the occurrence of hemorrhagic transformation (HT) after endovascular treatment is poorly studied, and which factors mediate their relationship remains largely unknown. We utilized nationwide registry data to explore the association of stroke subtype (cardioembolism versus large artery atherosclerosis) with HT and to identify the possible mediators. METHODS: A total of 1015 subjects were selected from the ANGEL-ACT registry (Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke)-a prospective consecutive cohort of acute large vessel occlusion patients undergoing endovascular treatment at 111 hospitals in China between November 2017 and March 2019-and divided into large artery atherosclerosis (n=538) and cardioembolism (n=477) according to the Trial of ORG 10172 in Acute Stroke Treatment criteria. The types of HT included any intracerebral hemorrhage (ICH), parenchymal hematoma, and symptomatic ICH within 24 hours after endovascular treatment. The association between stroke subtype and HT was analyzed using a logistic regression model. Mediation analysis was done to assess how much of the effect of stroke subtype on HT was mediated through the identified mediators. RESULTS: Stroke subtype (cardioembolism versus large artery atherosclerosis) was associated with increased risk of any ICH (29.8% versus 16.5%; odds ratio, 2.03 [95% CI, 1.22-3.36]), parenchymal hematoma (14.3% versus 5.4%; odds ratio, 2.90 [95% CI, 1.38-6.13]), and symptomatic ICH (9.9% versus 4.7%; odds ratio, 2.59 [95% CI, 1.09-6.16]) after adjustment for potential confounders. The more thrombectomy passes in cardioembolism patients had a significant mediation effect on the association of stroke subtype with increased risk of HT (any ICH, 15.9%; parenchymal hematoma, 13.4%; symptomatic ICH, 14.2%, respectively). CONCLUSIONS: Stroke subtype is an independent risk factor for HT within 24 hours following endovascular treatment among acute large vessel occlusion patients. Mediation analyses propose that stroke subtype contributes to HT partly through thrombectomy pass, suggesting a possible pathomechanistic link. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03370939.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tong X, Burgin WS, Ren Z, et al. Association of Stroke Subtype With Hemorrhagic Transformation Mediated by Thrombectomy Pass: Data From the ANGEL-ACT Registry. Stroke. 2022. PMID: 35354298. doi:10.1161/STROKEAHA.121.037411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。